Welcome to CDC stacks | The Costly burden of drug-resistant TB in the United States - 22071 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The Costly burden of drug-resistant TB in the United States
  • Published Date:
    March 2014
  • Language:
    English
Filetype[PDF-1.88 MB]


Details:
  • Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
  • Keywords:
  • Description:
    Multidrug-resistant (MDR) tuberculosis is a major health threat globally. Nearly half a million MDR TB cases are estimated to occur worldwide annually, including cases that are extensively drug-resistant (XDR). This infographic highlights that while MDR and XDR TB are relatively rare in the U.S., their treatment comes at a terrible price – it is very expensive, takes a long time to treat, disrupts lives, and has potentially life-threatening side effects.

  • Document Type:
    Poster
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. The Costly burden of drug-resistant TB in the United States
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
    Published:
    October 2016
    Description:
    Multidrug-resistant (MDR) tuberculosis is a major health threat globally. Nearly half a million MDR TB1 cases are estimated to occur worldwide annually, including cases that are extensively drug-resistant (XDR).2 : While MDR and XDR TB are relatively...
    File Type:
    Filetype[PDF - 2.13 MB]
  2. TB in the United States : a snapshot
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
    Published:
    MARCH 2018
    Series:
    CDC fact sheet
    Description:
    Slow Progress Underscores Need for Expanded Approach : Preliminary 2017 data show current declines in U.S. TB cases are too slow to reach TB elimination in this century. : • The TB rate declined slightly (-2.5%) from 2016 to 2017 with approximately...
    File Type:
    Filetype[PDF - 90.76 KB]
  3. TB in the United States : a snapshot
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
    Published:
    SEPTEMBER 2016
    Series:
    CDC fact sheet
    Description:
    Stalled Progress Underscores Need for Expanded Approach : After more than 20 years of progress toward tuberculosis (TB) elimination in the United States, recent data show the annual rate of TB (the number of new cases per 100,000 people) has leveled....
    File Type:
    Filetype[PDF - 68.03 KB]
  4. TB elimination : now is the time!
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    2/14/12
    Description:
    A Global perspective on tuberculosis -- What is TB? -- TB elimination: now is the time! -- The Price of neglect -- Back on track toward TB elimination -- TB continues to lurk beneath the surface -- HIV and TB coinfection – The Threat of drug-resist...
    File Type:
    Filetype[PDF - 1.80 MB]
  5. CDC's role in global tuberculosis control
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    8/27/2012
    Description:
    Tuberculosis (TB) is a challenging disease to diagnose, treat, and control globally and in the United States. TB is spread through the air from one person to another. TB bacteria are released into the air when a person with TB disease of the lungs or...
    File Type:
    Filetype[PDF - 9.47 MB]